Holen Sie sich die Stockscreener-App
189.91
0.98%
1.84
Handel nachbörslich:
190.02
0.11
+0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DHR?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$188.07
Offen:
$186.75
24-Stunden-Volumen:
7.09M
Relative Volume:
1.84
Marktkapitalisierung:
$135.91B
Einnahmen:
$23.82B
Nettoeinkommen (Verlust:
$3.77B
KGV:
36.88
EPS:
5.15
Netto-Cashflow:
$4.90B
1W Leistung:
-1.53%
1M Leistung:
-3.30%
6M Leistung:
-22.23%
1J Leistung:
-24.31%
1-Tages-Spanne:
$185.50
$196.33
1-Wochen-Bereich:
$185.50
$196.33
52-Wochen-Spanne:
$171.00
$281.70
Danaher Corp Stock (DHR) Company Profile
Firmenname
Danaher Corp
Sektor
Branche
Telefon
(202) 828-0850
Adresse
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Vergleichen Sie DHR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-04-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2025-03-14 | Hochstufung | Stifel | Hold → Buy |
| 2025-02-03 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-10-31 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-12-18 | Eingeleitet | HSBC Securities | Hold |
| 2023-12-13 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2023-12-07 | Herabstufung | Goldman | Buy → Neutral |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-05-01 | Eingeleitet | SVB Securities | Outperform |
| 2023-04-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-04-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-10-24 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-08-17 | Fortgesetzt | Bernstein | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-06-01 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-01-11 | Eingeleitet | Bernstein | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-10 | Bestätigt | BofA Securities | Buy |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Buy |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-04-07 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-03-03 | Fortgesetzt | Barclays | Overweight |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-06-16 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-04-02 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-03 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Fortgesetzt | Stifel | Hold |
| 2019-10-28 | Bestätigt | Needham | Buy |
| 2019-10-14 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-07-19 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-04-17 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2019-02-25 | Hochstufung | Janney | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-04-20 | Bestätigt | Stifel | Buy |
Alle ansehen
Danaher Corp Aktie (DHR) Neueste Nachrichten
Danaher Raises 2025 Earnings Outlook - The Motley Fool
Danaher Raises 2025 Earnings Outlook - Nasdaq
Top Manufacturing Stocks To ConsiderJuly 22nd - MarketBeat
Danaher Beats Q2 Revenue, EPS Forecasts - Nasdaq
Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline - Yahoo Finance
Danaher lifts annual profit forecast on pharma demand, China recovery - TradingView
Beacon Investment Advisory Services Inc. Sells 27,393 Shares of Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Corp. Exceeds Q2 Earnings Expectations with $555 Million ProfitNews and Statistics - IndexBox
Sustainable Growth Advisers LP Sells 709,054 Shares of Danaher Corporation (NYSE:DHR) - MarketBeat
DeDora Capital Inc. Cuts Stake in Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Reports Second Quarter 2025 Results - ADVFN Brasil
Danaher Corporation (NYSE:DHR) Shares Bought by KLP Kapitalforvaltning AS - MarketBeat
Alecta Tjanstepension Omsesidigt Grows Position in Danaher Corporation (NYSE:DHR) - MarketBeat
Steven Cohen's Strategic Moves: A Closer Look at Danaher Corp's Impact on His Portfolio - Yahoo.co
Danaher Corporation (NYSE:DHR) Shares Sold by VCI Wealth Management LLC - MarketBeat
Danaher Ups Profit Outlook Despite China Slowdown And Cost Pressures - Finimize
Danaher (DHR) Q2 2025 Earnings Call Transcript - The Globe and Mail
Bank Julius Baer & Co. Ltd Zurich Sells 147,134 Shares of Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Lifts Profit Outlook But Shares Slip Anyway - Finimize
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y - Yahoo.co
Universal Beteiligungs und Servicegesellschaft mbH Has $189.86 Million Stake in Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Raises Profit Outlook Despite Market Concerns - Finimize
Danaher's Focus on Continuous Improvement Helps Set It Apart From Peers - Morningstar
Danaher Stock Surge: Key Factors to Watch - StocksToTrade
Danaher lifts annual profit view on strength in diagnostics, names new CFO - 104.1 WIKY
What drives Danaher Corporation stock priceTriple-digit wealth increases - jammulinksnews.com
PFG Advisors Has $6.09 Million Holdings in Danaher Corporation (NYSE:DHR) - MarketBeat
Earnings call transcript: Danaher Q2 2025 beats estimates, stock dips - Investing.com
Danaher Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Danaher (NYSE:DHR) Updates FY 2025 Earnings Guidance - MarketBeat
Danaher (DHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Danaher Promotes Matthew Gugino to Finance Chief - Medical Product Outsourcing
Danaher 2025 Q2 Earnings Earnings Decline 37.4% Amid Revenue Growth - AInvest
Danaher (NYSE:DHR) Posts Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
Danaher Appoints Matthew Gugino as Chief Financial Officer - citybiz
US medtech group sent down despite upward adjustment - medwatch.com
Danaher stock slips despite Q2 beat (DHR:NYSE) - Seeking Alpha
OneAscent Financial Services LLC Acquires 2,255 Shares of Danaher Corporation (NYSE:DHR) - MarketBeat
Danaher Corporation Reports Better-than-Expected Results for Second Quarter 2025 - Tokenist
Danaher (DHR) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Danaher: Q2 Earnings Snapshot - The Washington Post
Danaher Corp (DHR) Q2 2025 Earnings: Adjusted EPS of $1.80 Beats Estimates, Revenue Hits $5.9 Billion - GuruFocus
Danaher names Matthew Gugino as next CFO in planned transition - Investing.com
Earnings Snapshot: Danaher surpasses Q2 estimates; raises FY25 Adj. EPS outlook - Seeking Alpha
Danaher Q2 2025 slides: Biotechnology segment drives growth amid mixed results - Investing.com India
Danaher shares slip despite Q2 beat, annual profit outlook hike - Investing.com
Danaher’s (NYSE:DHR) Q2 Sales Top Estimates But Quarterly Revenue Guidance Slightly Misses Expectations - Yahoo Finance
Danaher Corp. Q2 Profit Decreases, But Beats Estimates - Nasdaq
Danaher earnings beat by $0.16, revenue topped estimates - Investing.com Nigeria
Danaher Corporation Reports Second Quarter 2025 Results - TradingView
DANAHER CORP /DE/ SEC 10-Q Report - TradingView
Finanzdaten der Danaher Corp-Aktie (DHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):